期刊文献+

采用多种抗原测定静注人免疫球蛋白(pH4)中抗体Fc段生物学活性的初探 被引量:5

Determination on biologic activity of Fc fragment in intravenous immunoglobulin(pH4) by using multiple antigens
下载PDF
导出
摘要 目的初步探讨采用多种抗原测定静注人免疫球蛋白(IVIG)(pH4)中抗体的Fc段生物学活性,了解IVIG中抗体的Fc段生物学活性。方法采用补体活化的经典途径中免疫复合物激活补体的方法,将不同浓度的麻疹病毒、风疹病毒、乙肝表面抗原(HBsAg)、破伤风类毒素、脑膜炎球菌P64k外膜蛋白和白喉类毒素6种抗原分别致敏人O型血红细胞形成红细胞-抗原结合物;然后,6种致敏红细胞分别与IVIG孵育,与特异性抗体形成红细胞-抗原-抗体复合物;最后,此复合物与补体反应,在541 nm波长处读取吸光值,并绘制溶血反应动力学曲线,分别计算IVIG中针对上述6种抗原IgG的Fc段生物学活性。采用此方法,用6种抗原致敏的红细胞测定IVIG的Fc段生物学活性10次,验证此方法的重复性。结果麻疹病毒、风疹病毒、HBsAg、破伤风类毒素和脑膜炎球菌P64k外膜蛋白致敏的红细胞分别与供试品和补体反应后,测定的溶血反应动力学曲线较平缓,而白喉类毒素致敏的红细胞与供试品和补体反应后,测定的溶血反应动力学曲线下降明显,呈典型的"S"型曲线。计算结果显示,IVIG中针对此六种抗原的抗体Fc段生物学活性相对于参考品均大于80%。Fc段生物学检测方法重复性较好。结论采用多种抗原分别致敏红细胞,可以用来检测IVIG中多种抗体的Fc段生物学活性,为深入了解IVIG制品中的多种抗体的Fc段生物学活性奠定了基础。 Objective To determine biologic activity of Fc in IVIG(pH4) by using different antigens,and to understand biologic activity of Fc fragment of various IgG in IVIG(pH4).Methods The classical complement activation was carried out in determinination biological activity of Fc fragment in IVIG(pH4) by using 6 different antigens coupled-tanned red blood cells(RBC),respectively.First,It is by preparation of measles vaccines,rubella vaccines,HBsAg,tetanus toxin,P64k outer membrane protein of Meningococcus and diphtheria toxin coupling to RBC respectively.Then IVIG were added to the antigen coupled RBC to form a complex(antigen sensitized RBC and antibody).Finally,the complement was added to the complex.Measurement biologic activity of the Fc was by means of detection in 541 nm and making curves for haemolysis.Analysis was performed for 10 times by using 6 different antigen with different concentration coupled RBC,respectively.Verification was carried out in confirmation of the repetition for biologic activity of Fc in IVIG.Results The haemolysis curves were in slope lines for 5 different antigens(measles vaccines,rubella vaccines,HBsAg,tetanus toxin,and p64k protein on outer membrane protein of Meningococcus)coupled RBC.However,haemolysis curve for diphtheria toxoid coupled RBC was very typical and formed a classical "S"curve.The biologic activity of Fc fragment in IVIG could reach to more than 80% by using of 6 different antigens in comparison of reference materials.The test for repetition of biologic activity of Fc in IVIG was in a normal range.Conclusion Determination on biologic activity for Fc fragment in IVIG was attempted by using multiple antigens in this study,which provided a primary basis in this aspect.
出处 《微生物学免疫学进展》 2012年第6期25-29,共5页 Progress In Microbiology and Immunology
关键词 抗原 静注人免疫球蛋白 FC段 生物学活性 Antigens Intravenous Immunoglobulin(IVIG) Fc fragment Biologic activity
  • 相关文献

参考文献5

  • 1蹇远勇,刘文芳.如何全面评价静注人免疫球蛋白的安全性、有效性和耐受性[J].中国输血杂志,2008,21(1):75-78. 被引量:12
  • 2国家药典委员会.中华人民共和国药典(2010年版三部)[S]北京:中国医药科技出版社,2010附录XP人免疫球蛋白Fc段生物学活性测定法附录78.
  • 3Radosevich M,Burnouf T. Intravenous immunoglobulin G:trends in production methods,quality control and quality assurance[J].Vox Sanguinis,2010,(01):12-28.
  • 4王箐舟,程雅琴.静注丙球激活补体活性测定方法的建立[J].中国生物制品学杂志,2003,16(2):104-105. 被引量:5
  • 5Vroljak A,Trescec A,Benko B. A microassay for measurement of Fc function of human immunoglobulin preparations by using tetanus toxoid as antigen[J].Biologicals,2004,(02):78-83.doi:10.1016/j.biologicals.2004.03.001.

二级参考文献26

  • 1任跃明,程雅琴,倪道明.静脉注射人免疫球蛋白的质量控制[J].中国生物制品学杂志,2005,18(1):73-75. 被引量:12
  • 2[1]Bridonneau P, Marcilly H, Vernois-Martin M, et al. Liquid pasteurization of an immunoglobulin preparations without stabilizer: Effects on its biological and biochenical properties. Vox Sang, 1996,70:203.
  • 3[2]Deramoudt FX, Gilard C, Lepine N, et al. Bispecific anti-human red blood Rhesus-D antigen × anti FcγRI targeted antibody-dependent cellmediated cytotoxicity and phagocytosis by monoudear leucocytes. Clin.exp. Immunol, 1992,89:310.
  • 4Buchacher A, lberer G. Purification of intravenous immunoglobulin G from human plasma - aspects of yield and virus safety [J]. Biotchnol J,2006, ( 1 ) : 148 - 163
  • 5Gelfand EW. Difference between IVIG prouducts : Imapct on clinical outcome [J]. Int Immunopharmacol, 2006, ( 6 ) : 592-599
  • 6Siegel J, Fashp PD. The product : all intravenous immunoglobulins are not equivalent [..l]. Pharmacotherapy,2005,25(11 Pt 2) :785-845
  • 7Erwin W,Gelfand MD. Clinical consideratinons in IVIG treatment selction [C]//The 2006 American Socilty of Heath-sysem Pharmacists Midyear Clinical Meeting and Exhibition. CTE34606 newsletter V6.qxp 2121/2007.2006:7-10
  • 8Gelfand EW, Goldsmith J,leelelman H. Primary humoral immunodeficiency :optimizing IgG replacement therapy [J]. Immun Defic Founda :Clin Focus, 2003(10): 3-15
  • 9Buchacher A,Ibeer G.Purification of introvenous immunoglobulin G form human plasma-aspeets of yield and virus safaty [J]. Biotchnol J,2006,2(1):42-57
  • 10WHO Expert Committee on Biolgical standardiczation.Guidenlines on viral inactivation and removal procdeures intended to assure the viral safety of human blood plasma products[S]. Geneva : WHO, 2001 - 11-26-30

共引文献13

同被引文献29

  • 1任跃明,程雅琴,倪道明.静脉注射人免疫球蛋白的质量控制[J].中国生物制品学杂志,2005,18(1):73-75. 被引量:12
  • 2Aghaie A,Pourfatollah AA,Bathaie SZ,et al.Preparation,purification and virus inactivation of intravenous immunoglobulin from human plasma[J].Hum Antibodies,2010,19(1):1-6.
  • 3Radosevich M,Burnouf T.Intravenous immunoglobulin G:trends in production methods,quality control and quality assurance[J].Vox Sang,2010,98(1):12-28.
  • 4Georgakopoulos T,Tatford OC,Tan CS,et al.An improved method forthe determination of Fc function of immunoglobulins[J].Vox Sang,2009,96(2):133-137.
  • 5Nielsen H.Immunoglobulin preparations for intravenous administration.A review of their biologic activities and comparisonof various preparation methods[J].Allergy,1994,49(2):69-73.
  • 6Vrdoljak A,Trescec A,Benko B,et al.A microassay formeasurement of Fc function of human immunoglobulin preparationsby using tetanus toxoid as antigen[J].Biologicals,2004,32(2):78-83.
  • 7Georgakopoulos T,Komarraju S,Henry S,et al.An improved Fc function assay utilizing CMV antigen-coatedred blood cells generated with synthetic function-spacer-lipid constructs[J].Vox Sang,2012,102(1):72-78.
  • 8Ramasamy I,Tran E,Charnock A,et al.Flow-Cytometric method for the quantitation of the Fc function of intravenous immunoglobulin preparations[J].Vox Sang,2000,78(3):185-193.
  • 9Reipert BM,Ilas J,Carnewal C,et al.Fc function of a newintravenous immunoglobulin product:IVIG 10%triple virallyinactivated solution[J].Vox Sang,2006,91(3):256-263.
  • 10蹇远勇,刘文芳.如何全面评价静注人免疫球蛋白的安全性、有效性和耐受性[J].中国输血杂志,2008,21(1):75-78. 被引量:12

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部